INS and Hyperglycemia: For example, the administration of ILE can increase free fatty acid levels, leading to reduced insulin sensitivity in peripheral tissues, impaired glycolysis, and increased gluconeogenesis—all of which may contribute to hyperglycemia in preterm infants (15, 18, 19).